These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 33735893)

  • 1. Cognitive Performance in Relapsing-Remitting Multiple Sclerosis: At Risk or Impaired?
    Altieri M; Fratino M; Maestrini I; Dionisi C; Annecca R; Vicenzini E; Di Piero V
    Dement Geriatr Cogn Disord; 2020; 49(6):539-543. PubMed ID: 33735893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brief international cognitive assessment for multiple sclerosis (BICAMS): A danish validation study of sensitivity in early stages of MS.
    Marstrand L; Østerberg O; Walsted T; Skov AC; Schreiber KI; Sellebjerg F
    Mult Scler Relat Disord; 2020 Jan; 37():101458. PubMed ID: 31683230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Norwegian translation of the brief international cognitive assessment for multiple sclerosis (BICAMS).
    Skorve E; Lundervold AJ; Torkildsen Ø; Myhr KM
    Mult Scler Relat Disord; 2019 Nov; 36():101408. PubMed ID: 31610403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A one-year follow-up study of the Symbol Digit Modalities Test (SDMT) and the Paced Auditory Serial Addition Test (PASAT) in relapsing-remitting multiple sclerosis: an appraisal of comparative longitudinal sensitivity.
    López-Góngora M; Querol L; Escartín A
    BMC Neurol; 2015 Mar; 15():40. PubMed ID: 25886168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A preliminary validation of the brief international cognitive assessment for multiple sclerosis (BICAMS) tool in an Irish population with multiple sclerosis (MS).
    O'Connell K; Langdon D; Tubridy N; Hutchinson M; McGuigan C
    Mult Scler Relat Disord; 2015 Nov; 4(6):521-5. PubMed ID: 26590658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormalcortical thickness in relapsing-remitting multiple sclerosis, correlations with cognition impairment, and effect of modified Bushenyisui decoction on cognitive function of multiple sclerosis.
    Zhao X; Yang T; Cheng F; Yang S; Zhu W; Li S; Fan Y
    J Tradit Chin Med; 2021 Apr; 41(2):316-325. PubMed ID: 33825413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of cognitive impairment among Hungarian patients with relapsing-remitting multiple sclerosis and clinically isolated syndrome.
    Sandi D; Biernacki T; Szekeres D; Füvesi J; Kincses ZT; Rózsa C; Mátyás K; Kása K; Matolcsi J; Zboznovits D; Burány Z; Langane É; Vécsei L; Bencsik K
    Mult Scler Relat Disord; 2017 Oct; 17():57-62. PubMed ID: 29055476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive Impairment in Relapsing-Remitting Multiple Sclerosis Patients with Very Mild Clinical Disability.
    Migliore S; Ghazaryan A; Simonelli I; Pasqualetti P; Squitieri F; Curcio G; Landi D; Palmieri MG; Moffa F; Filippi MM; Vernieri F
    Behav Neurol; 2017; 2017():7404289. PubMed ID: 28912625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brief International Cognitive Assessment for Multiple Sclerosis scores are associated with the cortical thickness of specific cortical areas in relapsing-remitting patients.
    Davion JB; Lopes R; Jougleux C; Viard R; Dumont J; Leclerc X; Outteryck O
    Rev Neurol (Paris); 2022 Apr; 178(4):326-336. PubMed ID: 34657733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VALIDATION OF THE BRIEF INTERNATIONAL COGNITIVE ASSESSMENT FOR MULTIPLE SCLEROSIS (BICAMS) IN A LARGE COHORT OF RELAPSING-REMITTING MS PATIENTS.
    Drulović J; Tončev G; Nadj Č; Obradović D; Eraković J; Mesaroš Š; Čukić M; Aleksić D; Andabaka M; Ivanović J; Jovanović A; Kostić M; Marić G; Marković A; Martinović V; Parojčić A; Perić S; Sakalaš L; Suknjaja V; Vesić K; Vojvodić S; Vuković T; Benedict RHB; Pekmezović T
    Acta Clin Croat; 2022 Mar; 61(1):62-69. PubMed ID: 36398076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The correlation between EDSS and cognitive impairment in MS patients. Assessment of a Brazilian population using a BICAMS version.
    Caneda MA; Vecino MC
    Arq Neuropsiquiatr; 2016 Dec; 74(12):974-981. PubMed ID: 27991994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The subtleties of cognitive decline in multiple sclerosis: an exploratory study using hierarchichal cluster analysis of CANTAB results.
    Cabeça HLS; Rocha LC; Sabbá AF; Tomás AM; Bento-Torres NVO; Anthony DC; Diniz CWP
    BMC Neurol; 2018 Sep; 18(1):140. PubMed ID: 30200902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.
    Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Goretti B; Caniatti L; Di Monte E; Ferrazza P; Brescia Morra V; Lo Fermo S; Picconi O; Luccichenti G;
    Mult Scler; 2009 Jul; 15(7):779-88. PubMed ID: 19542262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. French validation of the Brief International Cognitive Assessment for Multiple Sclerosis.
    Maubeuge N; Deloire MSA; Brochet B; Erhlé N; Charré-Morin J; Saubusse A; Ruet A;
    Rev Neurol (Paris); 2021; 177(1-2):73-79. PubMed ID: 32713736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered individual behavioral and EEG parameters are related to the EDSS score in relapsing-remitting multiple sclerosis patients.
    Vázquez-Marrufo M; Galvao-Carmona A; Caballero-Díaz R; Borges M; Paramo MD; Benítez-Lugo ML; Ruiz-Peña JL; Izquierdo G
    PLoS One; 2019; 14(7):e0219594. PubMed ID: 31306457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Brief International Cognitive Assessment in Multiple Sclerosis (BICAMS): results from the German validation study.
    Filser M; Schreiber H; Pöttgen J; Ullrich S; Lang M; Penner IK
    J Neurol; 2018 Nov; 265(11):2587-2593. PubMed ID: 30171410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of the brief international cognitive assessment for multiple sclerosis (BICAMS) in the Portuguese population with multiple sclerosis.
    Sousa C; Rigueiro-Neves M; Miranda T; Alegria P; Vale J; Passos AM; Langdon D; Sá MJ
    BMC Neurol; 2018 Oct; 18(1):172. PubMed ID: 30332999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How to detect cognitive dysfunction at early stages of multiple sclerosis?
    Deloire MS; Bonnet MC; Salort E; Arimone Y; Boudineau M; Petry KG; Brochet B
    Mult Scler; 2006 Aug; 12(4):445-52. PubMed ID: 16900758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the brief international cognitive assessment for multiple sclerosis and the brief repeatable battery in multiple sclerosis patients.
    Niccolai C; Portaccio E; Goretti B; Hakiki B; Giannini M; Pastò L; Righini I; Falautano M; Minacapelli E; Martinelli V; Incerti C; Nocentini U; Fenu G; Cocco E; Marrosu MG; Garofalo E; Ambra FI; Maddestra M; Consalvo M; Viterbo RG; Trojano M; Losignore NA; Zimatore GB; Pietrolongo E; Lugaresi A; Pippolo L; Roscio M; Ghezzi A; Castellano D; Stecchi S; Amato MP
    BMC Neurol; 2015 Oct; 15():204. PubMed ID: 26472052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A two-year longitudinal follow-up of cognitive performance assessed by BICAMS in newly diagnosed patients with MS.
    Skorve E; Lundervold AJ; Torkildsen Ø; Myhr KM
    Mult Scler Relat Disord; 2020 Nov; 46():102577. PubMed ID: 33296975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.